Skip to content

Work Rehabilitation in Inflammatory Arthritis - Effectiveness and cost effectiveness of an occupational therapy (OT) job retention intervention: a pilot randomised controlled trial

Work Rehabilitation in Inflammatory Arthritis - Effectiveness and cost effectiveness of an occupational therapy (OT) job retention intervention: a pilot randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN76777720
Enrollment
100
Registered
2012-09-21
Start date
2011-10-01
Completion date
Unknown
Last updated
2020-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Musculoskeletal

Interventions

Participants are randomly allocated to receive VR or a stay at work information pack only. Control group: An information pack including the National Rheumatoid Arthritis Society and A

Sponsors

University of Salford (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. People with inflammatory arthritis (i.e., specifically early inflammatory arthritis [IA], rheumatoid arthritis [RA], psoriatic arthritis [PA]) 2. Aged 18 years and over 3. Able to read, write and understand English and in paid work (full or parttime) 4. People who answer "yes" to:"Do you have any concerns about your health affecting your ability to work over the next few years?" 5. Able to give informed consent 6. Male & Female; Upper Age Limit 65 years ; Lower Age Limit 18 years

Exclusion criteria

Exclusion criteria: People who are: 1. On extended sick leave (i.e. > 3 months) or unemployed (including not normally in paid employment or student) 2. Planning to retire or take early retirement (through choice or ill health) within the next 12 months 3. Already receiving or awaiting work rehabilitation services 4. Planning to move out of area or expecting joint replacement surgery in the next 6 months 5. Other conditions affecting work apart from arthritis (e.g. uncontrolled medical/ psychiatric problems

Design outcomes

Primary

MeasureTime frame
1. Work status 1.1. Work instability 1.2. Sickness absence Measured at 0, 6 and 9 months

Secondary

MeasureTime frame
1. Health status 1.1. Pain 1.2. Fatigue 1.3. Functional status 2. NHS costs Measured at 0, 6, 9 months

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 17, 2026